These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 17034032

  • 1. Timing of radiation in children with medulloblastoma/PNET.
    Santos MA, Viégas CM, Servidoni RA, Barros MH, Pinel MI, Araújo CM.
    Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
    [Abstract] [Full Text] [Related]

  • 2. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F, Baumert BG, Creak AL, Warrington AP, Ashley S, Traish D, Brada M.
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S, Burke A, Cherian S, Williams D, Nicholson J, Horan G, Jefferies S, Williams M, Earl HM, Burnet NG, Hatcher H.
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [Abstract] [Full Text] [Related]

  • 5. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS.
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [Abstract] [Full Text] [Related]

  • 6. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG, Barker JL, Ellenbogen RG, Geyer JR.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1161-4. PubMed ID: 15001259
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S, Krieger MD, Bowen I, McComb JG.
    J Neurosurg Pediatr; 2010 Aug 15; 6(2):131-6. PubMed ID: 20672933
    [Abstract] [Full Text] [Related]

  • 8. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R.
    J Clin Oncol; 2006 Sep 01; 24(25):4202-8. PubMed ID: 16943538
    [Abstract] [Full Text] [Related]

  • 9. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
    Taylor RE, Bailey CC, Robinson KJ, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Saran F, Walker DA, Pizer BL, Lashford LS, United Kingdom Children's Cancer Study Group Brain Tumour Committee, International Society of Paediatric Oncology.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1184-93. PubMed ID: 15001263
    [Abstract] [Full Text] [Related]

  • 10. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P, Pavelka Z, Dusek L, Hynkova L, Sterba J, Ondrova B, Princ D, Novotny T, Kostakova S.
    Neoplasma; 2007 Mar 15; 54(1):62-7. PubMed ID: 17203894
    [Abstract] [Full Text] [Related]

  • 11. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP).
    Rivera-Luna R, López E, Rivera-Marquez H, Rivera-Ortegón F, Altamirano-Alvarez E, Mercado G, Covarrubias G, Rueda-Franco F, Marhx-Bracho A, Gutiérrez P.
    Childs Nerv Syst; 2002 Feb 15; 18(1-2):38-42. PubMed ID: 11935242
    [Abstract] [Full Text] [Related]

  • 12. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 13. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
    Sirachainan N, Nuchprayoon I, Thanarattanakorn P, Pakakasama S, Lusawat A, Visudibhan A, Dhanachai M, Larbcharoensub N, Amornfa J, Shotelersuk K, Katanyuwong K, Tangkaratt S, Hongeng S.
    J Clin Neurosci; 2011 Apr 01; 18(4):515-9. PubMed ID: 21310618
    [Abstract] [Full Text] [Related]

  • 14. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
    Korah MP, Esiashvili N, Mazewski CM, Hudgins RJ, Tighiouart M, Janss AJ, Schwaibold FP, Crocker IR, Curran WJ, Marcus RB.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):106-12. PubMed ID: 19695790
    [Abstract] [Full Text] [Related]

  • 15. Survival of adults treated for medulloblastoma using paediatric protocols.
    Spreafico F, Massimino M, Gandola L, Cefalo G, Mazza E, Landonio G, Pignoli E, Poggi G, Terenziani M, Pedrazzoli P, Siena S, Fossati-Bellani F.
    Eur J Cancer; 2005 Jun 01; 41(9):1304-10. PubMed ID: 15869875
    [Abstract] [Full Text] [Related]

  • 16. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K, Taguchi H, Sawamura Y, Ikeda J, Aoyama H, Fujieda K, Ishii N, Kashiwamura M, Iwasaki Y, Shirato H.
    Jpn J Clin Oncol; 2008 Jul 01; 38(7):486-92. PubMed ID: 18573848
    [Abstract] [Full Text] [Related]

  • 17. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
    Rutkowski S, Gerber NU, von Hoff K, Gnekow A, Bode U, Graf N, Berthold F, Henze G, Wolff JE, Warmuth-Metz M, Soerensen N, Emser A, Ottensmeier H, Deinlein F, Schlegel PG, Kortmann RD, Pietsch T, Kuehl J, German Pediatric Brain Tumor Study Group.
    Neuro Oncol; 2009 Apr 01; 11(2):201-10. PubMed ID: 18818397
    [Abstract] [Full Text] [Related]

  • 18. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
    Sachivko NV, Konoplia NE, Petrovich SV, Sharak EV.
    Vopr Onkol; 2002 Apr 01; 48(3):318-21. PubMed ID: 12455354
    [Abstract] [Full Text] [Related]

  • 19. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR, Dunkel IJ, Souweidane MM, Khakoo Y, Lyden DC, Gilheeney SW, Becher OJ, Budnick AS, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e15-20. PubMed ID: 21481547
    [Abstract] [Full Text] [Related]

  • 20. Long-term results of a prospective study on the treatment of medulloblastoma in adults.
    Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M.
    Cancer; 2007 Nov 01; 110(9):2035-41. PubMed ID: 17823910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.